Cancer Research at the Fralin Biomedical Research Institute
At the Fralin Biomedical Research Institute, dedicated investigators in two centers strive to improve therapies and better outcomes in a range of cancers, from childhood cancers to breast cancer to brain cancers, including acute myeloid leukemia, diffuse midline glioma, and glioblastoma multiforme. Research teams are exploring drug development, the role of genes in cancer, focused ultrasound and biomatarials to improve existing cancer treatments such as immunotherapy. With laboratories in Roanoke, Virginia, and Washington, D.C., the research institute devotes significant resources to making groundbreaking discoveries to address the challenges of the second leading cause of death globally.
-
Home Item
Jenny Munson, Ph.D. , homeProfessor, Director, Cancer Research Center – Roanoke
-
Home Item
Christopher Hourigan, DM, DPhil, FRCP , homeProfessor, Director, Cancer Research Center – D.C.
-
Article Item
The hidden currents of the brain , article Date: Oct 21, 2025 - -
Article Item
Unraveling the secrets of ‘chemo brain’ , article Date: Oct 13, 2025 - -
Article Item
Cancer researchers shape emerging strategies for immunotherapy , article Date: Oct 07, 2025 -
-
Article ItemHigh school student takes on pediatric cancer , article
Through the Focused Ultrasound Foundation’s Global Internship Program, Mason Liu is tackling pediatric cancer research in the Fralin Biomedical Research Institute’s D.C. labs.
Date: Oct 01, 2025 - -
Article ItemResearcher advances new approach to blood cancer treatment , article
Christopher Hourigan, a physician-scientist, is leading nationwide efforts to develop advanced techniques to better identify residual disease and tailor treatment for each patient with acute myeloid leukemia, a highly fatal blood cancer.
Date: Sep 30, 2025 - -
Article ItemPredicting where a deadly brain cancer might go next , article
Cancer researcher Jennifer Munson describes a novel method for identifying where glioblastoma is likely to recur based on fluid moving through and near the tumor.
Date: Sep 09, 2025 - -
Article Item'Big Science, Small Pod' podcast: What do you do when your body is its own enemy? , article
Cancer researcher and physician-scientist Cheng-Chia "Fred" Wu describes how the blood-brain barrier, meant to protect your brain from viruses and toxins, also stands between cancers and the drugs that could kill them. Focused ultrasound could change that.
Date: Aug 13, 2025 - -
Article ItemImmunotherapy for leukemia may change the bone marrow environment, cancer researchers find , article
Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia have found that a type of treatment — immunotherapy — may help change the environment where cancer cells live, possibly helping the immune system respond more effectively.
Date: Jul 31, 2025 - -
Article ItemHard-to-treat cancers respond to combination therapy using a new class of drugs , article
In a powerful new approach, Fralin Biomedical Research Institute scientists use advanced gene editing to study potential dual therapy for lung, brain, and pancreatic cancers.
Date: Jul 25, 2025 - -
Article ItemScientists uncover immune cells that help prostate cancer resist treatment and a way to stop them , article
Scientists at the Fralin Biomedical Research Institute identified a subtype of immune cells that helps advanced prostate cancer evade the body’s defenses, suggesting a new approach for treatment.
Date: Jul 10, 2025 -
Page 1 of 14 | 138 Results
Recent Media Coverage
-
Redirect ItemNeuroscience News: Lymphatic Damage Tied to Chemo Brain Fog , redirect Date: Oct 13, 2025 -
-
Redirect Item
-
Redirect ItemBioengineer: Unraveling the Mysteries of ‘Chemo Brain’ , redirect Date: Oct 13, 2025 -
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
Page 1 of 31 | 303 Results